International Business Machines Corporation is a global technology company focused on hybrid cloud and artificial intelligence. IBM operates across four primary segments: Software, which includes the Red Hat portfolio and enterprise offerings such as watsonx; Consulting; Infrastructure, spanning the IBM Z mainframe franchise, Power servers, and storage; and Financing. The company's competitive strengths include a deep enterprise customer base, a large recurring software revenue stream, and an expanding position in enterprise AI and quantum computing. Investors follow the stock for its software growth, consulting backlog, dependable dividend, and free cash flow generation.
IBM shares rose approximately 11% over the last 30 days, climbing from a close of about $220.51 in early October to roughly $245 by early November 2026. The move was front-loaded around the company's third-quarter earnings release in late October, when the stock jumped into the low-$250s before consolidating. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the past quarter, the picture is more modest. From roughly $233 in early August to about $245 in early November, the stock gained around 5%. The period was volatile: shares touched the high-$240s in mid-September, pulled back to about $220 in late September, then rallied to roughly $258 in late October before easing again. IBM remains below its 52-week high near $332 and is down about 16% year to date, reflecting the broader recovery underway since mid-2026.
The primary catalyst was IBM's third-quarter 2026 earnings report. The company posted revenue of $17.10 billion, up about 5% year over year and above the roughly $16.82 billion consensus, alongside adjusted earnings per share of $2.95, which beat the $2.86 estimate. Software revenue rose about 8%, led by Red Hat, which grew 11%, and OpenShift annual recurring revenue accelerated above 30% growth. Infrastructure revenue reached $3.7 billion, up 5% in constant currency, while Consulting revenue grew a more modest 2% in constant currency.
Management maintained full-year revenue growth guidance of 4% to 5% in constant currency but raised the low end of its software outlook to 7% to 8% and increased its free cash flow growth expectation to more than $1 billion. Several analysts responded with higher targets, including Goldman Sachs, Stifel, Jefferies, and Barclays. The announcement of a quantum error-correction collaboration with AMD and Oak Ridge National Laboratory, plus the unveiling of IBM's Quantum System Two in Chicago, added to the positive tone. Notably, shares showed intraday and after-hours volatility after CEO Arvind Krishna cautioned that corporate clients are increasingly concerned about whether AI spending is delivering measurable returns.
The quarterly trend reflects IBM's ongoing recovery from a sharp single-day decline of roughly 25% in July 2026, when management flagged that customers had deferred mainframe and software spending amid broader worries about AI's impact on traditional software. The third quarter showed evidence of that shortfall being recaptured, with a large portion of previously slipped infrastructure and software business closing during the period. Improving enterprise AI sentiment, a growing consulting backlog with generative AI embedded in a meaningful share of engagements, and a $1 billion CHIPS award supporting a U.S.-based quantum foundry all contributed to a stabilizing narrative over the past three months.
Looking ahead, investors should monitor whether IBM can sustain its software growth and recapture the remaining deferred infrastructure business through the fourth quarter. The IBM Z mainframe cycle, Red Hat and OpenShift momentum, and consulting demand trends are key operating indicators. Broader questions around enterprise AI return on investment and IT budget allocation remain a central theme across the technology sector. Macroeconomic factors, including interest rates and currency movements, may also influence results. Analyst consensus sits near a "Moderate Buy" with an average price target in the mid-$260s. As always, these are informational observations rather than investment recommendations.
In my own research process, I often turn to Tickeron’s AI Trading Bots to test how automated strategies might approach names like IBM across different market conditions. These tools help highlight measurable performance patterns without relying on subjective forecasts, offering a practical layer to traditional fundamental review. They have become a regular part of how I cross-check short-term signals against longer-term trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 166 of 271 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for IBM moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 24 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 55 cases where IBM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In 50 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.700) is normal, around the industry mean (2.898). P/E Ratio (21.379) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.028) settles around the average of (0.224) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices